Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsSolid TumorsProtocol groupPlasma cell neoplasmsSarcomasTransplantationDiseaseEwing SarcomaMultiple MyelomaStem Cell Transplantation, AutologousSubgroupICD10C40.-C41.-C90.-C90.0-Z94.80MeSHSarcoma, EwingTransplantation, AutologousSequenceEWING 2012 Arm A VIDEEWING 2012 Arm B VDC/IEChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanTreosulfanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanTreosulfanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanTreosulfanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanTreosulfanUrsodeoxycholic acidValaciclovirNo. Substances911Protocol classificationTherapy classificationalternativecurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationFirst lineseveral possibleTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorAnderton JDirksen UDiseaseEwing Sarkom, Erstlinieprimär disseminiertes Ewing Sarkom, unter 50 J.OriginEuro Ewing 2012 protocolFunctional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment (EWING 2008)Protokolle in Überarbeitung 2 protocols foundBusulfan 0.8 / Melphalan 140, Autologous Stem Cell Transplantation (PID571 V1.2)Melphalan 140 / Treosulfan 12, Ewing Sarcoma, Autologous Stem Cell Transplantation (PID1396 V2.2)
